A detailed history of Kennedy Investment Group transactions in Novartis Ag stock. As of the latest transaction made, Kennedy Investment Group holds 6,830 shares of NVS stock, worth $750,002. This represents 0.3% of its overall portfolio holdings.

Number of Shares
6,830
Previous 6,750 1.19%
Holding current value
$750,002
Previous $776 Million 14.39%
% of portfolio
0.3%
Previous 0.36%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Jan 22, 2025

BUY
$96.78 - $117.18 $7,742 - $9,374
80 Added 1.19%
6,830 $665 Million
Q2 2024

Jul 18, 2024

BUY
$92.57 - $107.37 $624,847 - $724,747
6,750 New
6,750 $719 Million

Others Institutions Holding NVS

About NOVARTIS AG


  • Ticker NVS
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,151,000,064
  • Market Cap $236B
  • Description
  • Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...
More about NVS
Track This Portfolio

Track Kennedy Investment Group Portfolio

Follow Kennedy Investment Group and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Kennedy Investment Group, based on Form 13F filings with the SEC.

News

Stay updated on Kennedy Investment Group with notifications on news.